SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pro-Pharmaceuticals, Inc. Selects SAFC to Ramp-up the Manufacture of DAVANAT(R) for Anticipated Use in Clinical Trials & Sales in Colombia